А. N. Polyakov

5.1k total citations
50 papers, 445 citations indexed

About

А. N. Polyakov is a scholar working on Nuclear and High Energy Physics, Radiation and Pulmonary and Respiratory Medicine. According to data from OpenAlex, А. N. Polyakov has authored 50 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Nuclear and High Energy Physics, 17 papers in Radiation and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in А. N. Polyakov's work include Nuclear physics research studies (19 papers), Nuclear Physics and Applications (15 papers) and Pancreatic and Hepatic Oncology Research (7 papers). А. N. Polyakov is often cited by papers focused on Nuclear physics research studies (19 papers), Nuclear Physics and Applications (15 papers) and Pancreatic and Hepatic Oncology Research (7 papers). А. N. Polyakov collaborates with scholars based in Russia, United States and Kazakhstan. А. N. Polyakov's co-authors include Yu. S. Tsyganov, A. M. Sukhov, V. K. Utyonkov, F. Sh. Abdullin, Yu. V. Lobanov, Yu. Ts. Oganessian, K. Subotić, V. G. Subbotin, S. Iliev and Michael Dudley and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of Applied Physics.

In The Last Decade

А. N. Polyakov

39 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
А. N. Polyakov Russia 10 294 138 113 78 77 50 445
Avinash Agarwal India 14 287 1.0× 132 1.0× 153 1.4× 11 0.1× 85 1.1× 43 541
I. Tomandl Czechia 15 374 1.3× 285 2.1× 110 1.0× 27 0.3× 127 1.6× 68 813
N. Imai Japan 12 370 1.3× 188 1.4× 216 1.9× 6 0.1× 96 1.2× 95 771
D. Adams United Kingdom 11 147 0.5× 32 0.2× 166 1.5× 29 0.4× 10 0.1× 18 447
K. Pretzl Switzerland 11 247 0.8× 52 0.4× 130 1.2× 14 0.2× 18 0.2× 44 480
T. Marchi Italy 12 133 0.5× 306 2.2× 92 0.8× 9 0.1× 31 0.4× 40 411
O. Svoboda Czechia 11 67 0.2× 143 1.0× 144 1.3× 5 0.1× 109 1.4× 50 413
A. Mazzi Italy 15 111 0.4× 312 2.3× 143 1.3× 15 0.2× 10 0.1× 27 583
R. Chiba Japan 12 143 0.5× 34 0.2× 126 1.1× 8 0.1× 29 0.4× 35 428
David Wahl United Kingdom 12 119 0.4× 210 1.5× 115 1.0× 36 0.5× 8 0.1× 27 726

Countries citing papers authored by А. N. Polyakov

Since Specialization
Citations

This map shows the geographic impact of А. N. Polyakov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by А. N. Polyakov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites А. N. Polyakov more than expected).

Fields of papers citing papers by А. N. Polyakov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by А. N. Polyakov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by А. N. Polyakov. The network helps show where А. N. Polyakov may publish in the future.

Co-authorship network of co-authors of А. N. Polyakov

This figure shows the co-authorship network connecting the top 25 collaborators of А. N. Polyakov. A scholar is included among the top collaborators of А. N. Polyakov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with А. N. Polyakov. А. N. Polyakov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Polyakov, А. N., et al.. (2024). Place of tyrosine kinase inhibitors in the first line of treatment of hepatocellular carcinoma. Meditsinskiy sovet = Medical Council. 64–72.
3.
Polyakov, А. N., et al.. (2024). Acinar cells of the pancreas as an independent predictor of the development of postoperative pancreatic fistula: A review. SHILAP Revista de lepidopterología. 26(2). 210–217.
4.
Polyakov, А. N., et al.. (2024). E-ΔE detection module of DGFRS-2 setup. Applied Radiation and Isotopes. 212. 111431–111431.
5.
Стилиди, И. С., et al.. (2024). Second line chemotherapy for advanced biliary cancer: FOLFOX versus FOLFIRI: Analysis of retrospective and prospective data. SHILAP Revista de lepidopterología. 26(2). 202–209. 1 indexed citations
6.
Polyakov, А. N., et al.. (2023). Functional outcomes of pancreaticoduodenoctomy. Annaly khirurgicheskoy gepatologii = Annals of HPB surgery. 28(1). 71–79. 1 indexed citations
7.
Polyakov, А. N., et al.. (2023). Irreversible electroporation in locally advanced pancreatic cancer. Pirogov Russian Journal of Surgery. 29–29. 1 indexed citations
8.
Tsyganov, Yu. S., et al.. (2022). Flexible algorithms for background suppression in heavy ion induced nuclear reactions. SHILAP Revista de lepidopterología. 6(1). 18–31. 3 indexed citations
9.
Polyakov, А. N., et al.. (2022). Pancreatodigestive anastomosis: the key to a favorable outcome of pancreaticoduodenal resection. Annaly khirurgicheskoy gepatologii = Annals of HPB surgery. 27(3). 92–99. 2 indexed citations
10.
Polyakov, А. N., et al.. (2022). Repeated irreversible electroporation in a locally advanced pancreatic cancer. SHILAP Revista de lepidopterología. 9(4). 114–122. 1 indexed citations
11.
Fedyanin, М. Yu., U. A. Boyarskikh, Andrey Kechin, et al.. (2022). Concordance between the tumor mutational status and circulating tumor DNA in patients with colorectal cancer. SHILAP Revista de lepidopterología. 12(1). 27–34. 1 indexed citations
13.
Tsyganov, Yu. S., et al.. (2022). Flexible Scenario for Background Suppression in Heavy Element Research. Physics of Atomic Nuclei. 85(12). 1981–1987. 1 indexed citations
14.
Krupinova, Julia, Н. Г. Мокрышева, Anna Eremkina, et al.. (2020). Challenges in the differential diagnosis of multiple endocrine neoplasia syndrome type 1 with isolated family hyperparathyroidism. Clinical Medicine (Russian Journal). 98(3). 218–225. 1 indexed citations
15.
Fedyanin, М. Yu., И. А. Покатаев, A. Tryakin, et al.. (2019). FOLFOXIRI in patients with colon cancer and isolated non-resectable liver metastases: phase II prospective non-randomized single-center study. SHILAP Revista de lepidopterología. 9(4). 21–31. 1 indexed citations
16.
Polyakov, А. N., et al.. (2019). Liver Functional Evaluation Using Gadoxetic Acid Versus the Gold Standard Hepatobiliary Scintigraphy in Patients with Bile Duct Diseases. SHILAP Revista de lepidopterología. 100(4). 200–208. 1 indexed citations
17.
Polyakov, А. N., et al.. (2019). Metastatic renal cell carcinoma to the pancreas: experience of surgical treatment. Pirogov Russian Journal of Surgery. 25–25. 5 indexed citations
18.
Polyakov, А. N., et al.. (2018). Comparison of Outgoing ir Radiation Spectra Measured in Different Yea. Исследования Земли из космоса. 65–72. 1 indexed citations
19.
Subotić, K., et al.. (2017). Measurement of the life-times distribution of 216Po. Nuclear Instruments and Methods in Physics Research Section A Accelerators Spectrometers Detectors and Associated Equipment. 868. 119–121. 1 indexed citations
20.
Polyakov, А. N., et al.. (2015). Surgical and combined treatment of patients with cholangiocellular carcinoma. Pirogov Russian Journal of Surgery. 11–11. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026